Search Results - "Rokicka, M"

Effect of taxonomic diversification of microalgae harvested from eutrophicated reservoirs on the chemical composition of biomass and effectiveness of methane fermentation by Dębowski, M., Zieliński, M., Kupczyk, K., Rokicka, M., Hajduk, A.

“…The objective of this study was to determine the possibility of using microalgae biomass from natural water bodies as a substrate for methane fermentation and…”
Get full text

Effectiveness of dairy wastewater treatment in a bioreactor based on the integrated technology of activated sludge and hydrophyte system by Dębowski, M, Zieliński, M, Krzemieniewski, M, Rokicka, M, Kupczyk, K

“…The aim of this study was to determine the effectiveness of dairy wastewater treatment in the integrated technology based on the simultaneous use of the…”
Get full text

Fatal combined immune hemolytic anemia after double cord blood transplantation in imatinib-resistant CML by Rokicka, M, Styczynski, J, Michalewska, B, Torosian, T, Tomaszewska, A, Gronkowska, A, Pogorzala, M, Wysocki, M, Lakomy, M, Wiktor-Jedrzejczak, W

Get full text

Transient oral cavity and skin complications after mucositis preventing therapy (palifermin) in a patient after allogeneic PBSCT. Case history by Grzegorczyk-Jaźwińska, A, Kozak, I, Karakulska-Prystupiuk, E, Rokicka, M, Ganowicz, E, Dwilewicz-Trojaczek, J, Górska, R

“…The aim of this study was to assess the state of oral mucosa in a patient after allo-PBSCT who has received palifermin, a recombinant human keratinocyte growth…”
Get full text

Evaluation of relative anti-myeloma activity of high-dose melphalan followed by the first peripheral blood stem cell transplantation, as compared with the second transplantation, and to VAD chemotherapy by Awedan, A, Król, M, Blajer, B, Rokicka, M, Torosian, T, Urbanowska, E, Wiktor-Jedrzejczak, W

“…Current treatment in multiple myeloma consists of three courses of chemotherapy in low doses with subsequent hematopoietic stem cell mobilization to the…”
Get full text

Allogeneic haematopoietic stem cell transplantation from the third party donor in a recipient of allogeneic kidney graft by Snarski, E, Torosian, T, Rokicka, M, Paluszewska, M, Tomaszewska, A, Gronkowska, A, Urbanowska, E, Krol, M, Koperski, L, Wiktor-Jedrzejczak, W

“…When allogeneic hematopoietic cells are transplanted to a solid organ recipient there is a danger of organ graft rejection as these hematopoietic cells are HLA…”
Get full text

CERA (Continuous Erythropoiesis Receptor Activator) in patients with multiple myeloma: An exploratory phase I–II dose escalation study by Dmoszynska, A., Kloczko, J., Rokicka, M., Hellmann, A., Spicka, I.

“…Abstract only…”
Get full text

CERA (Continuous Erythropoiesis Receptor Activator) in patients with multiple myeloma: An exploratory phase I–II dose escalation study by Dmoszynska, A., Kloczko, J., Rokicka, M., Hellmann, A., Spicka, I.

“…Abstract only…”
Get full text

Tyrosine Residues of the Erythropoietin Receptor Are Dispensable for Erythroid Differentiation of Human CD34+ Progenitors by Fichelson, S., Chrétien, S., Rokicka-Piotrowicz, M., Bouhanik, S., Gisselbrecht, S., Mayeux, P., Lacombe, C.

“…To study the role of the cytoplasmic domain and particularly the tyrosine residues of the erythropoietin receptor (EpoR) in erythroid differentiation of human…”
Get full text

The Relation of Inflammaging With Skeletal Muscle Properties in Elderly Men by Zembron-Lacny, Agnieszka, Dziubek, Wioletta, Wolny-Rokicka, Edyta, Dabrowska, Grazyna, Wozniewski, Marek

“…Aging is associated with a progressive decline of muscle mass and/or the qualitative impairment of the muscle tissue. There is growing evidence of the…”
Get full text

A dose exploration, phase I/II study of administration of continuous erythropoietin receptor activator once every 3 weeks in anemic patients with multiple myeloma receiving chemotherapy by Dmoszynska, Anna, Kloczko, Janusz, Rokicka, Malgorzata, Hellmann, Andrzej, Spicka, Ivan, Eid, Joseph E

“…Medical University of Lublin, Lublin, Poland; Medical University, Bialystok, Poland; Medical University of Warsaw, Warsaw, Poland; Gdansk Medical Academy,…”
Get full text

Triple transplantation of autologous peripheral blood stem cells each time following conditioning with 100 mg/m2 of melphalan for multiple myeloma patients in poor performance status by ROKICKA, M, URBANOWSKA, E, TOROSIAN, T, DWILEWICZ-TROJACZEK, J, AWEDAN, A, PALUSZEWSKA, M, WIKTOR-JEDRZEJCZAK, W

“…Approximately one third of multiple myeloma patients (below 60 years) are diagnosed either in advanced disease or with significant comorbidities. Many other…”
Get full text

Triple transplantation of autologous peripheral blood stem cells each time following conditioning with 100 mg/m 2 of melphalan for multiple myeloma patients in poor performance status by Rokicka, M, Urbanowska, E, Torosian, T, Dwilewicz-Trojaczek, J, Awedan, A, Paluszewska, M, Wiktor-Jedrzejczak, W

“…Approximately one third of multiple myeloma patients (below 60 years) are diagnosed either in advanced disease or with significant comorbidities. Many other…”
Get full text

Simultaneous transplantation of two allogeneic units of cord blood in an adult patient with acute myeloblastic leukemia: a case report by Wiktor-Jedrzejczyk, Wiesław, Rokicka, Małgorzata, Urbanowska, Elzbieta, Torosian, Tigran, Graczyk-Pol, Elzbieta, Tomaszewska, Agnieszka, Król, Małgorzata, Paluszewska, Monika, Gronkowska, Anna, Ziarkiewicz-Wróblewska, Bogna, Jółkowska, Justyna, Witt, Michał

“…The major obstacle to the therapeutic use of hematopoietic transplantation is the unavailability of matched, unrelated marrow donors for the large number of…”
Get more information

Comparison of various clinical and hematological features of various types of non-Hodgkin lymphomas of a low degree of malignancy in relation to age groups by Dwilewicz-Trojaczek, J, Paprocka, E, Rokicka, M

Get more information

Analysis of causes for anemia in patients with multiple myeloma by Rokicka-Piotrowicz, M, Paszkowska, M, Król, M, Kuratowska, Z

“…Pathogenetic mechanism of myeloma (MM) associated anaemia may involve: decreased level of erythropoietin (Epo) production, insufficient response to this…”
Get more information

Fetal hemoglobin by Rokicka-Piotrowicz, M

“…The paper presents a current state of knowledge on the regulation of Hb synthesis in physiology and pathology. Possible mechanisms of HbF synthesis switching…”
Get more information

Evaluation of treating anemia in patients undergoing chronic dialysis with small doses of human recombinant erythropoietin by Marusza, W, Matuszkiewicz-Rowińska, J, Tomik, Z, Andrzejewski, A, Rokicka, M, Paszkowska, M, Drygieniec, D, Bobilewicz, D, Zawadzka, M, Abbas-Fatah, A

“…The aim of the study was to assess the efficacy of low dose subcutaneous (sc) recombinant human erythropoietin (rHuEpo) therapy in hemodialysis (hd) patients,…”
Get more information

Anemia and erythropoietin level in some hematology malignancies by Rokicka-Piotrowicz, M, Paszkowska, M, Kuratowska, Z

“…Pathogenesis of anemia in patients with myeloma, low grade lymphoma and acute leukaemia was the aim of the study. Erythropoietin (Epo) serum level was detected…”
Get more information

Disorders of the hematopoietic system in patients with Hodgkin's disease before treatment by Paluszewska, M, Rokicka, M, Kuratowska, Z

Get more information